- Home
- UCAR vs COCP Comparison
UCAR vs COCP Comparison
Compare UCAR & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCAR
- COCP
- Stock Information
- Founded
- UCAR 2013
- COCP 2006
- Country
- UCAR China
- COCP United States
- Employees
- UCAR N/A
- COCP N/A
- Industry
- UCAR Retail-Auto Dealers and Gas Stations
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- UCAR Consumer Discretionary
- COCP Health Care
- Exchange
- UCAR Nasdaq
- COCP Nasdaq
- Market Cap
- UCAR 13.3M
- COCP 15.4M
- IPO Year
- UCAR 2023
- COCP N/A
- Fundamental
- Price
- UCAR $3.94
- COCP $1.70
- Analyst Decision
- UCAR
- COCP Strong Buy
- Analyst Count
- UCAR 0
- COCP 1
- Target Price
- UCAR N/A
- COCP $6.00
- AVG Volume (30 Days)
- UCAR 105.4K
- COCP 24.3K
- Earning Date
- UCAR 07-22-2025
- COCP 08-13-2025
- Dividend Yield
- UCAR N/A
- COCP N/A
- EPS Growth
- UCAR N/A
- COCP N/A
- EPS
- UCAR N/A
- COCP N/A
- Revenue
- UCAR $6,067,871.00
- COCP N/A
- Revenue This Year
- UCAR N/A
- COCP N/A
- Revenue Next Year
- UCAR N/A
- COCP N/A
- P/E Ratio
- UCAR N/A
- COCP N/A
- Revenue Growth
- UCAR 124.09
- COCP N/A
- 52 Week Low
- UCAR $2.30
- COCP $1.12
- 52 Week High
- UCAR $9.43
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- UCAR 54.16
- COCP 60.02
- Support Level
- UCAR $3.58
- COCP $1.46
- Resistance Level
- UCAR $3.99
- COCP $1.95
- Average True Range (ATR)
- UCAR 0.51
- COCP 0.10
- MACD
- UCAR -0.05
- COCP 0.03
- Stochastic Oscillator
- UCAR 38.10
- COCP 51.76
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).